Public Calendar: March 26 - April 1, 2023
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.
Official Name: Robert M. Califf, M.D., MACC, Commissioner for Food and Drugs
Event Date: 03/29/2023
Location: Washington, DC
Subject: National Academy of Medicine's Leadership Consortium Members Dinner (Attendee Only)
FDA Participant/Group: N/A
Non FDA Participant/Group: Academia, industry, and government
Event Date: 03/30/2023
Location: Washington, DC
Subject: National Academy of Medicine's Leadership Consortium (Attendee Only)
FDA Participant/Group: N/A
Non FDA Participant/Group: Academia, industry, and government
Event Date: 03/30/2023
Location: Virtual
Subject: Expanding Access to Naloxone
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several stakeholders interested in access to naloxone
Event Date: 03/31/2023
Location: Virtual
Subject: National Institute of Health Workshop on Inclusive Participation in Clinical Research
FDA Participant/Group: RICHARDAE ARAOJO; ELENI ANAGNOSTIADIS;
Non FDA Participant/Group: Government, academia, and industry
Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner
No Significant Event
Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs
No Significant Event
Official Name: Jim Sigg, Deputy Commissioner for Operations
No Significant Event
Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy
Event Date: 03/30/2023
Location: Virtual
Subject: FDA Engagements in Mexico
FDA Participant/Group: KATHERINE SERRANO; MICHELLE RODRIGUEZ; VESA VUNIQI;
Non FDA Participant/Group: Amina Achaibou (Federal Commission for the Protection Against Sanitary Risks);
Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs
Event Date: 03/28/2023
Location: Virtual
Subject: ORA / Veterinary Medicine Roundtable; Attendee
FDA Participant/Group: SARAH CLARK LYNN; DILLARD WOODY; LAURA HUFFMAN; ELIZABETH MILLER; BRITTANY SHELTON; JUDITH MCMEEKIN;
Non FDA Participant/Group: Alex Sullivan, Lea Ann McNee, Susan Winckler (Regan Udall);
Official Name: Erica Jefferson, Associate Commissioner for External Affairs
No Significant Event
Official Name: Namandjé N. Bumpus, Ph.D., Chief Scientist
No Significant Event
Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research
Event Date: 03/27/2023
Location: Virtual
Subject: Introductory Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Janice Chang (TransCelerate);
Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research
Event Date: 03/29/2023
Location: Philadelphia, PA
Subject: Pharma USA 2023 Conference; Speaker: FDA Regulatory Update
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the Reuters Events - Pharma USA 2023
Event Date: 03/30/2023
Location: Washington, DC
Subject: Presidential Advisory Council on HIV/AIDS Meeting; FDA Update
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of Presidential Advisory Council on HIV/AIDS Meeting
Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health
Event Date: 03/28/2023
Location: Silver Spring, MD
Subject: Medical Device Reporting
FDA Participant/Group: N/A
Non FDA Participant/Group: Angus Metcalfe, Jeanne Greathouse, Manuela Gazzard, Mark Thirlwell (British Standards Institution);
Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition
Event Date: 03/27/2023
Location: Washington, DC
Subject: Food Allergy Research and Education (FARE) Courage at Congress; Speaker: Food Allergy Safety, Treatment, Education, and Research (FASTER) Act and Beyond
FDA Participant/Group: PATRICIA HANSEN; JENNIFER DOOREN;
Non FDA Participant/Group: Industry, advocates, and other stakeholders
Event Date: 03/30/2023
Location: Virtual
Subject: FDA Nutrition Initiatives
FDA Participant/Group: ROBIN MCKINNON;
Non FDA Participant/Group: Peter Rowan (Mars Inc.);
Event Date: 03/31/2023
Location: Virtual
Subject: Alliance for A Stronger FDA Webinar; FY 2024 FDA Budget
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, academia, regulatory, and other stakeholders
Official Name: Brian King, Ph.D., Director, Center for Tobacco Products
Event Date: 03/28/2023
Location: Virtual
Subject: Disposable Ends
FDA Participant/Group: N/A
Non FDA Participant/Group: Representative Sheila Cherfilus-McCormick (D-TX)
Event Date: 03/30/2023
Location: Buffalo, NY
Subject: Introductory Meetings
FDA Participant/Group: N/A
Non FDA Participant/Group: Several representatives from the Roswell Park Department of Health Behavior and staff from the New York State Department of Health Bureau of Tobacco Control
Event Date: 03/31/2023
Location: Buffalo, NY
Subject: Introductory Meetings
FDA Participant/Group: N/A
Non FDA Participant/Group: Several representatives from the University of Buffalo Department of Epidemiology and Environmental Health
Event Date: 03/31/2023
Location: Buffalo, NY
Subject: Saxon Graham Lecture; The Hitchhiker’s Guide to Tobacco Regulation: Promise and Peril in an Increasingly Complex Landscape
FDA Participant/Group: N/A
Non FDA Participant/Group: Several representatives from the University of Buffalo
Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine
No Significant Event
Official Name: Tucker Patterson, Ph.D., Acting Director, National Center for Toxicological Research
No Significant Event
Official Name: Mark Raza, J.D., Chief Counsel
No Significant Event